NISOURCE INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NISOURCE INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $4.87B | Feb 20, 2018 |
| FY2017 | Dec 31, 2016 | $4.49B | Feb 20, 2018 |
| FY2017 | Dec 31, 2015 | $4.65B | Feb 20, 2018 |
| FY2016 | Dec 31, 2014 | $5.27B | May 8, 2017 |
| FY2015 | Dec 31, 2013 | $4.63B | Feb 18, 2016 |
| FY2014 | Dec 31, 2012 | $5.03B | Feb 18, 2015 |
| FY2013 | Dec 31, 2011 | $5.75B | Feb 18, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.52B | Feb 11, 2026 |
| FY2024 | Dec 31, 2024 | $5.28B | Feb 12, 2025 |
| FY2025 | Dec 31, 2023 | $5.35B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $5.74B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $4.73B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $4.47B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $5.05B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $4.99B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $4.73B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $4.39B | Feb 20, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.37B | Feb 20, 2018 |
| FY2017 | Sep 30, 2017 | $917.00M | Feb 20, 2018 |
| FY2017 | Jun 30, 2017 | $990.70M | Feb 20, 2018 |
| FY2017 | Mar 31, 2017 | $1.60B | Feb 20, 2018 |
| FY2017 | Dec 31, 2016 | $1.30B | Feb 20, 2018 |
| FY2017 | Sep 30, 2016 | $861.30M | Feb 20, 2018 |
| FY2017 | Jun 30, 2016 | $897.60M | Feb 20, 2018 |
| FY2017 | Mar 31, 2016 | $1.44B | Feb 20, 2018 |
| FY2016 | Dec 31, 2015 | $1.10B | May 8, 2017 |
| FY2016 | Sep 30, 2015 | $817.20M | May 8, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.21B | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | $902.50M | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | $962.70M | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | $1.61B | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $1.40B | Feb 17, 2021 |
| FY2020 | Sep 30, 2019 | $931.50M | Feb 17, 2021 |
| FY2020 | Jun 30, 2019 | $1.01B | Feb 17, 2021 |
| FY2020 | Mar 31, 2019 | $1.87B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $1.46B | Feb 28, 2020 |
| FY2019 | Sep 30, 2018 | $895.00M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $929.50M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $760.40M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $714.30M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $804.10M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $584.90M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $84.40M | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | ($172.90M) | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | ($4.70M) | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | $75.60M | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | ($139.30M) | Feb 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.84B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.46B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.30B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.27B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.01B | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $218.10M | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | $92.80M | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | $91.70M | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | $148.20M | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | ($38.00M) | Feb 17, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.36B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.78B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.94B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.41B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.22B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.10B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $1.58B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $540.10M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $742.20M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $803.30M | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.78B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.61B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.65B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.20B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.84B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.76B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $1.80B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.82B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.70B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.48B | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.86B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $31.79B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $31.08B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $26.74B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $24.16B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $22.04B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $22.66B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $21.80B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $19.96B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $18.69B | Feb 20, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.45B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $8.68B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $8.27B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $7.58B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $6.95B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $5.75B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $5.99B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $5.75B | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $4.32B | Feb 28, 2020 |
| FY2019 | Dec 31, 2016 | $4.07B | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.49B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.49B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.49B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.49B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.49B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $1.69B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.69B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $1.69B | Feb 20, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($315.20M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($711.70M) | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | ($967.00M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | ($1.21B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($1.58B) | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | ($1.77B) | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | ($1.37B) | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | ($1.40B) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($1.07B) | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | ($972.20M) | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $110.10M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $156.60M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.25B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $40.80M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $84.20M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $116.50M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $139.30M | Feb 23, 2022 |
| FY2019 | Dec 31, 2018 | $112.80M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $29.00M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $26.40M | Feb 20, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $6.43B | Feb 18, 2016 |
| FY2014 | Dec 31, 2014 | $8.47B | Feb 18, 2015 |
| FY2013 | Dec 31, 2013 | $8.19B | Feb 18, 2014 |
| FY2012 | Dec 31, 2012 | $7.37B | Feb 19, 2013 |
| FY2011 | Dec 31, 2011 | $6.63B | Feb 24, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 478.43M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 469.82M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 447.38M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 412.14M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 405.30M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 391.76M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 382.14M | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | 372.36M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 337.02M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 323.16M | Feb 20, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $530.40M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $481.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $413.50M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $381.50M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $345.20M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $321.60M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $298.50M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $273.30M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $229.10M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $205.50M | Feb 20, 2019 |